Overview |
bs-21780R-APC-Cy5 |
PRKD1/PKC mu Polyclonal Antibody, APC-Cy5 Conjugated |
IF(IHC-P), IF(IHC-F), IF(ICC) |
Human, Rat |
Mouse, Dog, Cow, Sheep, Pig, Horse |
Specifications |
APC-Cy5 |
Rabbit |
KLH conjugated synthetic peptide derived from human PRKD1/PKC mu |
191-290/912 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
5587 |
Q15139 |
Cytoplasm, Cell membrane |
nPKC D1; nPKC mu; nPKC-D1; nPKC-mu; nPKCD1; nPKCmu; PKC; PKC MU; PKCM; PKCmu; PKD 1; PRKD1; PKD; PKD1; PRKCM; PRKD 1; Prkd1; Protein kinase C mu; Protein kinase C mu type; Protein kinase D; Protein kinase D1; Serine/threonine protein kinase D1; Serine/threonine-protein kinase D1; KPCD1_HUMAN. |
Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress through activation of NF-kappa-B. |
Application Dilution |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |